John F. Bierbaum

Director/Board Member at Holstein USA, Inc.

80 year

Consumer Services

Health Technology

Profile

John F.
Bierbaum has been a Director of Northfield Laboratories, Inc. since September 2002.
He is Chief Financial Officer of Archdiocese of Saint Paul and Minneapolis.
Mr. Bierbaum is a Director of Holstein USA, Inc. He was a Senior Officer of PepsiAmericas, Inc. Mr. Bierbaum had been a Consultant of PepsiAmericas, Inc. since May 2003.
He received a BS degree from the University of Minnesota in 1967 and is a Certified Public Accountant.

John F. Bierbaum active positions

Companies	Position	Start
Holstein USA, Inc.	Director/Board Member	-

All active positions of John F. Bierbaum

Former positions of John F. Bierbaum

Companies	Position	End
Archdiocese of Saint Paul & Minneapolis Archdiocese of Saint Paul & Minneapolis Other Consumer ServicesConsumer Services Archdiocese of Saint Paul & Minneapolis operates elementary and secondary schools. The company was headquartered in St. Paul, MN.	Director of Finance/CFO	2014-12-02
Northfield Laboratories, Inc. Northfield Laboratories, Inc. BiotechnologyHealth Technology The Company's principal activity is to develop, manufacture, market and distribute a hemoglobin-based blood substitute product. The Company's product, PolyHeme(R) blood substitute, provides an alternative to transfused blood for use in the treatment of acute blood loss. The company uses a proprietary process of separation, filtration, chemical modification purification and formulation to produce PolyHeme. PolyHeme is designed to avoid potential undesirable effects such as vasoconstriction, kidney dysfunction, liver dysfunction and gastrointestinal distress. Clinical trials of PolyHeme have been conducted at multiple locations in the United States. The company has entered into license agreements with Pfizer Inc and Hemocare Ltd an Israeli corporation to develop manufacture and distribute PolyHeme in certain European, Middle Eastern and African countries. The Company is in development stage.	Director/Board Member	2009-11-09

See the detail of John F. Bierbaum's experience

Training of John F. Bierbaum

University of Minnesota

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John F. Bierbaum's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Northfield Laboratories, Inc. Northfield Laboratories, Inc. BiotechnologyHealth Technology The Company's principal activity is to develop, manufacture, market and distribute a hemoglobin-based blood substitute product. The Company's product, PolyHeme(R) blood substitute, provides an alternative to transfused blood for use in the treatment of acute blood loss. The company uses a proprietary process of separation, filtration, chemical modification purification and formulation to produce PolyHeme. PolyHeme is designed to avoid potential undesirable effects such as vasoconstriction, kidney dysfunction, liver dysfunction and gastrointestinal distress. Clinical trials of PolyHeme have been conducted at multiple locations in the United States. The company has entered into license agreements with Pfizer Inc and Hemocare Ltd an Israeli corporation to develop manufacture and distribute PolyHeme in certain European, Middle Eastern and African countries. The Company is in development stage.	Health Technology
Holstein USA, Inc.
Archdiocese of Saint Paul & Minneapolis Archdiocese of Saint Paul & Minneapolis Other Consumer ServicesConsumer Services Archdiocese of Saint Paul & Minneapolis operates elementary and secondary schools. The company was headquartered in St. Paul, MN.	Consumer Services

See company connections

Stock Market
Insiders
John F. Bierbaum